228 related articles for article (PubMed ID: 38779517)
21. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy.
Cerrito L; Ainora ME; Mosoni C; Borriello R; Gasbarrini A; Zocco MA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230569
[TBL] [Abstract][Full Text] [Related]
23. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs.
Reggidori N; Bucci L; Santi V; Stefanini B; Lani L; Rampoldi D; Ghittoni G; Farinati F; Masotto A; Stefanini B; Mega A; Biasini E; Foschi FG; Svegliati-Baroni G; Sangiovanni A; Campani C; Raimondo G; Vidili G; Gasbarrini A; Celsa C; Di Marco M; Giannini EG; Sacco R; Brunetto MR; Azzaroli F; Magalotti D; Morisco F; Rapaccini GL; Nardone G; Vitale A; Trevisani F;
JHEP Rep; 2023 Aug; 5(8):100784. PubMed ID: 37520672
[TBL] [Abstract][Full Text] [Related]
24. Early detection and curative treatment of early-stage hepatocellular carcinoma.
Kudo M
Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S144-8. PubMed ID: 16234064
[TBL] [Abstract][Full Text] [Related]
25. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
26. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review.
Candita G; Rossi S; Cwiklinska K; Fanni SC; Cioni D; Lencioni R; Neri E
Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832113
[TBL] [Abstract][Full Text] [Related]
27. Current Practice of Hepatocellular Carcinoma Surveillance.
Loho IM; Siregar L; Waspodo AS; Hasan I
Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
[TBL] [Abstract][Full Text] [Related]
28. Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease.
Huang Y; Wallace MC; Adams LA; MacQuillan G; Garas G; Ferguson J; Samuelson S; Tibballs J; Jeffrey GP
J Clin Gastroenterol; 2018 Jul; 52(6):551-556. PubMed ID: 28858944
[TBL] [Abstract][Full Text] [Related]
29. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
[TBL] [Abstract][Full Text] [Related]
30. [Current Status and Future Directions of Hepatocellular Carcinoma Surveillance Test Based on Cost-effective Analysis].
An J
Korean J Gastroenterol; 2021 Nov; 78(5):255-260. PubMed ID: 34824183
[TBL] [Abstract][Full Text] [Related]
31. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
Adeniji N; Dhanasekaran R
Hepatol Commun; 2021 Dec; 5(12):1972-1986. PubMed ID: 34533885
[TBL] [Abstract][Full Text] [Related]
32. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
33. Advances in post-operative prognostic models for hepatocellular carcinoma.
He Z; She X; Liu Z; Gao X; Lu LU; Huang J; Lu C; Lin Y; Liang R; Ye J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):191-206. PubMed ID: 36915996
[TBL] [Abstract][Full Text] [Related]
34. Natural history of hepatocellular carcinoma.
Colombo M
Ann Ital Chir; 2008; 79(2):91-7. PubMed ID: 18727270
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
[TBL] [Abstract][Full Text] [Related]
36. Current role of ultrasound for the management of hepatocellular carcinoma.
Maruyama H; Yoshikawa M; Yokosuka O
World J Gastroenterol; 2008 Mar; 14(11):1710-9. PubMed ID: 18350602
[TBL] [Abstract][Full Text] [Related]
37. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma.
Maruyama K; Yoshikawa M; Yokosuka O
JNMA J Nepal Med Assoc; 2008; 47(171):156-66. PubMed ID: 19079385
[TBL] [Abstract][Full Text] [Related]
39. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
